Therapeutic options to treat autoimmune hepatitis in 2009

Digestive Diseases

Volumn 28, Issue 1, 2010, Pages 93-98

  Strassburg, Christian P ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Autoimmune hepatitis; Azathioprine; Budesonide; Immunosuppression; Remission; Steroids

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; BUDESONIDE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; PREDNISOLONE; PREDNISONE; STEROID; TACROLIMUS;

ABDOMINAL DISCOMFORT; ALTERNATIVE MEDICINE; AUTOIMMUNE HEPATITIS; CHOLESTATIC HEPATITIS; CLINICAL FEATURE; CLINICAL TRIAL; CUSHINGOID SYNDROME; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; FIRST PASS EFFECT; GRAFT FAILURE; HEMATOLOGIC DISEASE; HISTOPATHOLOGY; HUMAN; LEUKOPENIA; LIVER BIOPSY; LIVER TRANSPLANTATION; LOW DRUG DOSE; MONOTHERAPY; NAUSEA; NEPHROTOXICITY; PRIORITY JOURNAL; PROGNOSIS; RASH; RECURRENT DISEASE; RECURRENT INFECTION; REMISSION; REVIEW; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

HEPATITIS, AUTOIMMUNE; HUMANS; LIVER TRANSPLANTATION; RECURRENCE;

EID: 77952556076     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000282071     Document Type: Review

References (16)

1. Alvarez F, Berg PA, Bianchi FB, et al: International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatology 1999;31:929-938.
2. Strassburg CP, Manns MP: Transition of care between paediatric and adult gastroenterology. Autoimmune hepatitis. Best Pract Res Clin Gastroenterol 2003;17:291-306.
3. Strassburg CP, Manns MP: Autoantibodies and autoantigens in autoimmune hepatitis. Semin Liver Dis 2002;22:339-352.
4. Strassburg CP, Cornberg M: Diagnostics and therapy of hepatitis (in German). Internist (Berl) 2009;50:1358-1368.
5. Manns MP, Strassburg CP: Autoimmune hepatitis: clinical challenges. Gastroenterology 2001;120:1502-1517.
6. Kirk AP, Jain S, Pocock S, Thomas HC, Sherlock S: Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis. Gut 1980;21:78-93.
7. Strassburg CP, Manns MP: Treatment of autoimmune hepatitis. Semin Liver Dis 2009;29:273-285.
8. Johnson PJ, McFarlane IG, Williams R: Azathioprine for long-term maintenance of remission in autoimmune hepatitis. N Engl J Med 1995;333:958-963.
9. Strassburg CP, Bahr MJ, Becker T, Klempnauer J, Manns MP: Progress in immunosuppression (in German). Chirurg 2008;79:149-156.
10. Wiegand J, Schuler A, Kanzler S, et al: Budesonide in previously untreated autoimmune hepatitis. Liver Int 2005;25:927-934.
11. Richardson PD, James PD, Ryder SD: Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine. J Hepatol 2000;33:371-375.
12. Hennes EM, Oo YH, Schramm C, et al: Mycophenolate mofetil as second line therapy in autoimmune hepatitis? Am J Gastroenterol 2008;103:3063-3070.
13. Strassburg CP, Manns MP: Liver transplantation: indications and results. Internist (Berl) 2009;50:550-560.
14. Weismuller TJ, Negm A, Becker T, et al: The introduction of MELD-based organ allocation impacts 3-month survival after liver transplantation by influencing pretrans-plant patient characteristics. Transpl Int 2009;22:970-978.
15. Vogel A, Heinrich E, Bahr MJ, et al: Long-term outcome of liver transplantation for autoimmune hepatitis. Clin Transplant 2004;18:62-69.
16. Rowe IA, Webb K, Gunson BK, Mehta N, Haque S, Neuberger J: The impact of disease recurrence on graft survival following liver transplantation: a single centre experience. Transpl Int 2008;21:459-465.